CooperVision Practitioner Website
Partnering with eye care professionals to help the world see better every day.
We support each practice’s overall business success while helping them bring high quality contact lenses to wearers with an extraordinary wide range of vision needs.1
Over 43 million contact lens wearers wear CooperVision® contact lenses worldwide.†2
CooperVision is #1 for the range of soft contact lens prescription options it offers worldwide.‡3
CooperVision® contact lens range can provide correction for 99.96% of all your patients.1
Why CooperVision® is Your Go-To Brand
Commitment to myopia management
CooperVision is a world leader in myopia management, committed to partnering with eye care professionals to help children with myopia receive evidence-based4-6 treatment for a lifetime of better vision.*§◊4,5
Innovative technology
Our commitment to innovation makes it possible for more people to wear contact lenses.
A contact lens for every stage in life
Making contact lenses accessible to more wearers for a wide range of correction needs and budgets, at any stage in life.
Technology driven services and tools
Our commitment to innovation makes it possible for more people to wear contact lenses.
We design with intention & are powered by people
We thoughtfully design our products and packaging† to make efficient use of resources while starting to reduce our carbon footprint.**††7 We collaborate and innovate, embracing our ingenuity to care for our planet and each other.
*Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
†Based on internal estimates for rolling 12 month sales data, as of October 2024. Includes 1 Day disposable, 2 weekly replacement, monthly replacement disposable contact lenses and specialty lens designs including Ortho-k and sclerals.
‡Based on Rx option combinations (sphere, cylinder, axis & add) manufactured, across all soft lenses in sphere, toric & multifocal, in SiHy and hydrogel from 4 main manufacturers. Includes 1 Day, 2 weekly, and monthly disposable contact lenses. Cosmetic & Photochromatic contact lenses not included. Multiple base curve variants not included.
§MiSight® 1 day, designed for myopia control, shows sustained slowing of eye growth over time on average. While eyes are still growing; children fit ages 8-12 and followed for 6-years. n=40.
◊Compared to a single vision 1-day lens.
¶Refers to continuous manufacturing improvement processes undertaken by CooperVision to reduce its Scope 1 and 2 carbon emissions.
**Carbon footprint is limited to Scope 1 and 2 emissions, defined as: Scope 1 emissions are direct emissions from owned or controlled sources. Scope 2 emissions are indirect emissions from the generation of purchased energy.
††CooperVision's 2022 Environmental, Social, and Governance Report.
References:
1. CVI data on file, 2021. Rx coverage database n=101,973 aged 14 to 70 years.
2. CVI data on file, 2024.
3. CVI data on file, 2024. Based on Tyler’s Quarterly and competitor websites, 9/2024.
4. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. OVS 2019; 96(8):556-567.
5. Chamberlain P, et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. OVS 2022 Mar 1;99(3):204-212.
6. Chamberlain P, Arumugam B, et al. Myopia progression on cessation of Dual-Focus contact lens wear: MiSight 1 day 7 year findings. OVS 2025 In Press;98:E-abstract 210049.
7. CVI data on file, 2023.
18892 11/25